Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3405 | 1608 | 26.1 | 50% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
41 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY | 99449 |
3405 | 2 | LOTEPREDNOL ETABONATE//PRODRUG//ANTEDRUG | 1608 |
13198 | 1 | PRODRUG//DIFFUSION CELL EXPERIMENTS//DERMAL PRODRUG | 854 |
21088 | 1 | LOTEPREDNOL ETABONATE//CHEMICAL DELIVERY SYSTEM//NBP ASSAY | 434 |
24189 | 1 | ANTEDRUG//ANTIINFLAMMATORY//TIPREDANE | 320 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LOTEPREDNOL ETABONATE | authKW | 313881 | 1% | 72% | 23 |
2 | PRODRUG | authKW | 216890 | 10% | 7% | 166 |
3 | ANTEDRUG | authKW | 211047 | 1% | 65% | 17 |
4 | CHEMICAL DELIVERY SYSTEM | authKW | 175757 | 1% | 51% | 18 |
5 | DIFFUSION CELL EXPERIMENTS | authKW | 135622 | 1% | 71% | 10 |
6 | DERMAL PRODRUG | authKW | 132916 | 0% | 100% | 7 |
7 | ANTIINFLAMMATORY | address | 121520 | 0% | 80% | 8 |
8 | TIPREDANE | authKW | 113928 | 0% | 100% | 6 |
9 | TRANSFORMED POTTS GUY EQUATION | authKW | 113928 | 0% | 100% | 6 |
10 | MUTUAL PRODRUG | authKW | 109358 | 1% | 48% | 12 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 11666 | 25% | 0% | 410 |
2 | Pharmacology & Pharmacy | 9933 | 46% | 0% | 741 |
3 | Chemistry, Multidisciplinary | 2243 | 26% | 0% | 416 |
4 | Chemistry, Organic | 961 | 12% | 0% | 200 |
5 | Ophthalmology | 329 | 4% | 0% | 72 |
6 | Crystallography | 154 | 3% | 0% | 53 |
7 | Endocrinology & Metabolism | 129 | 5% | 0% | 76 |
8 | Polymer Science | 47 | 3% | 0% | 53 |
9 | Dermatology | 32 | 2% | 0% | 26 |
10 | Biochemistry & Molecular Biology | 29 | 9% | 0% | 139 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIINFLAMMATORY | 121520 | 0% | 80% | 8 |
2 | CENQAM | 42721 | 0% | 75% | 3 |
3 | MOL CELLULAR PHARMACOL DIABET | 42721 | 0% | 75% | 3 |
4 | USTAV CHEM LEC | 37976 | 0% | 100% | 2 |
5 | CECF | 31029 | 1% | 15% | 11 |
6 | ANAL PHARM CHEM | 18988 | 0% | 100% | 1 |
7 | ANAL SUPERFICI | 18988 | 0% | 100% | 1 |
8 | ANALYT CHEM MED CHEM | 18988 | 0% | 100% | 1 |
9 | BASE POSTDOCTORAL SCI | 18988 | 0% | 100% | 1 |
10 | BIO DEV MARSEILLE CHIM BIOMOL | 18988 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 21434 | 8% | 1% | 134 |
2 | JOURNAL OF PHARMACEUTICAL SCIENCES | 15208 | 6% | 1% | 95 |
3 | PHARMACEUTICAL RESEARCH | 7375 | 3% | 1% | 56 |
4 | STEROIDS | 6604 | 2% | 1% | 39 |
5 | ACTA PHARMACEUTICA NORDICA | 6449 | 0% | 4% | 8 |
6 | PHARMAZIE | 4259 | 3% | 1% | 45 |
7 | JOURNAL OF MEDICINAL CHEMISTRY | 3101 | 4% | 0% | 60 |
8 | ALLERGY & CLINICAL IMMUNOLOGY INTERNATIONAL-JOURNAL OF THE WORLD ALLERGY ORGANIZATION | 1944 | 0% | 5% | 2 |
9 | OMNI | 1724 | 0% | 9% | 1 |
10 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1718 | 1% | 1% | 18 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LOTEPREDNOL ETABONATE | 313881 | 1% | 72% | 23 | Search LOTEPREDNOL+ETABONATE | Search LOTEPREDNOL+ETABONATE |
2 | PRODRUG | 216890 | 10% | 7% | 166 | Search PRODRUG | Search PRODRUG |
3 | ANTEDRUG | 211047 | 1% | 65% | 17 | Search ANTEDRUG | Search ANTEDRUG |
4 | CHEMICAL DELIVERY SYSTEM | 175757 | 1% | 51% | 18 | Search CHEMICAL+DELIVERY+SYSTEM | Search CHEMICAL+DELIVERY+SYSTEM |
5 | DIFFUSION CELL EXPERIMENTS | 135622 | 1% | 71% | 10 | Search DIFFUSION+CELL+EXPERIMENTS | Search DIFFUSION+CELL+EXPERIMENTS |
6 | DERMAL PRODRUG | 132916 | 0% | 100% | 7 | Search DERMAL+PRODRUG | Search DERMAL+PRODRUG |
7 | TIPREDANE | 113928 | 0% | 100% | 6 | Search TIPREDANE | Search TIPREDANE |
8 | TRANSFORMED POTTS GUY EQUATION | 113928 | 0% | 100% | 6 | Search TRANSFORMED+POTTS+GUY+EQUATION | Search TRANSFORMED+POTTS+GUY+EQUATION |
9 | MUTUAL PRODRUG | 109358 | 1% | 48% | 12 | Search MUTUAL+PRODRUG | Search MUTUAL+PRODRUG |
10 | ROBERTS SLOAN EQUATION | 101264 | 0% | 67% | 8 | Search ROBERTS+SLOAN+EQUATION | Search ROBERTS+SLOAN+EQUATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KHAN, MOF , LEE, HJ , (2008) SYNTHESIS AND PHARMACOLOGY OF ANTI-INFLAMMATORY STEROIDAL ANTEDRUGS.CHEMICAL REVIEWS. VOL. 108. ISSUE 12. P. 5131-5145 | 69 | 86% | 27 |
2 | BODOR, N , (1999) RECENT ADVANCES IN RETROMETABOLIC DESIGN APPROACHES.JOURNAL OF CONTROLLED RELEASE. VOL. 62. ISSUE 1-2. P. 209 -222 | 63 | 85% | 13 |
3 | BODOR, N , BUCHWALD, P , (2000) SOFT DRUG DESIGN: GENERAL PRINCIPLES AND RECENT APPLICATIONS.MEDICINAL RESEARCH REVIEWS. VOL. 20. ISSUE 1. P. 58 -101 | 72 | 52% | 104 |
4 | BODOR, N , BUCHWALD, P , (1999) RECENT ADVANCES IN THE BRAIN TARGETING OF NEUROPHARMACEUTICALS BY CHEMICAL DELIVERY SYSTEMS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 36. ISSUE 2-3. P. 229 -254 | 57 | 57% | 84 |
5 | KHAN, MOF , PARK, KK , LEE, HJ , (2005) ANTEDRUGS: AN APPROACH TO SAFER DRUGS.CURRENT MEDICINAL CHEMISTRY. VOL. 12. ISSUE 19. P. 2227-2239 | 39 | 76% | 11 |
6 | PROKAI, L , PROKAI-TATRAI, L , BODOR, N , (2000) TARGETING DRUGS TO THE BRAIN BY REDOX CHEMICAL DELIVERY SYSTEMS.MEDICINAL RESEARCH REVIEWS. VOL. 20. ISSUE 5. P. 367 -416 | 66 | 46% | 69 |
7 | BODOR, N , (2000) RECENT ADVANCES IN RETROMETABOLIC DRUG DESIGN AND TARGETING APPROACHES.PHARMAZIE. VOL. 55. ISSUE 3. P. 163-166 | 33 | 94% | 12 |
8 | BODOR, N , BUCHWALD, P , (1999) RETROMETABOLIC DRUG DESIGN: PRINCIPLES, EXAMPLES AND COMPUTATIONAL TECHNIQUES.MAGYAR KEMIAI FOLYOIRAT. VOL. 105. ISSUE 9. P. 337 -362 | 56 | 51% | 1 |
9 | JAIN, V , KISHORE, D , BHARDWAJ, YR , PAREEK, A , (2014) CHEMICAL DELIVERY SYSTEMS AND SOFT DRUGS: RETROMETABOLIC APPROACHES OF DRUG DESIGN.SAUDI PHARMACEUTICAL JOURNAL. VOL. 22. ISSUE 4. P. 290 -302 | 25 | 76% | 0 |
10 | SHEPPARD, JD , COMSTOCK, TL , CAVET, ME , (2016) IMPACT OF THE TOPICAL OPHTHALMIC CORTICOSTEROID LOTEPREDNOL ETABONATE ON INTRAOCULAR PRESSURE.ADVANCES IN THERAPY. VOL. 33. ISSUE 4. P. 532 -552 | 28 | 58% | 1 |
Classes with closest relation at Level 2 |